{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Millburn",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95420",
      "recalling_firm": "Advanced Accelerator Applications USA, Inc.",
      "address_1": "57 E Willow St",
      "address_2": "N/A",
      "postal_code": "07041-1416",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "FL, MA, NJ, NY, PA, and VA",
      "recall_number": "D-0007-2025",
      "product_description": "Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications,  57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61",
      "product_quantity": "99 doses",
      "reason_for_recall": "CGMP deviations",
      "recall_initiation_date": "20240923",
      "center_classification_date": "20241003",
      "report_date": "20241009",
      "code_info": "Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024  Lot#: LPS240920C-16, 25-Sep-2024"
    }
  ]
}